When a child is diagnosed with cancer, parents are thrust overnight into the role of pharmacist, nurse, and safety officer for a home medication regimen that can involve dozens of drugs, complex dosing schedules, and unforgiving consequences for error. A new qualitative study from Australia suggests that the greatest risks in this high-stakes situation may not stem from what caregivers fail to understand, but from how health services deliver and coordinate the information they are expected to absorb. The research, published in BMC Health Services Research, examined the medication information needs and preferences of caregivers of children receiving cancer treatment at a tertiary paediatric oncology centre in New South Wales, one of the most linguistically and culturally diverse regions of the country.
The study, led by Micaella Sotera Hansen of the Sydney Pharmacy School at the University of Sydney, together with colleagues from the University of Sydney, Blacktown Hospital, the Cancer Centre for Children at The Children’s Hospital at Westmead, Sydney Nursing School, and the University of New South Wales, took a deliberately ground-level view of the problem. Rather than measuring knowledge with questionnaires, the team conducted semi-structured interviews, held remotely, with fifteen caregivers of children undergoing cancer treatment. The interviews were then analysed using reflexive thematic analysis, a qualitative method in which researchers iteratively code the data and construct themes while remaining explicitly aware of how their own perspectives shape interpretation. This approach is well suited to capturing the texture of lived experience: not just whether caregivers could recall a drug’s side effects, but how they actually went about finding, checking, and acting on medication information in daily life.
The setting matters. Paediatric oncology care is increasingly delivered to populations that differ in language, cultural context, and familiarity with healthcare systems, yet communication and information delivery often proceed on the assumption of a shared language and shared understanding between clinicians and families. When that assumption fails, the result is not merely inconvenience. Children with cancer are frequently managed with complex, home-based medication regimens in which chemotherapy agents, antiemetics, antimicrobials, and supportive-care drugs must be given on precise schedules, sometimes with narrow therapeutic windows. A misunderstanding about dose, timing, or preparation is, in that context, a patient safety issue in the most direct sense. The researchers set out to understand how variation in caregivers’ engagement with medication information might contribute to inequities in access to, and use of, that information.
The first major finding is striking in its consistency: across the entire sample, regardless of where caregivers were born or what language they spoke at home, the core medication information needs were the same. Caregivers described cognitive overload at the point treatment began, when a torrent of new drug names, instructions, and warnings arrives alongside the emotional shock of diagnosis. They preferred information that was staged over time rather than delivered in a single overwhelming burst, and delivered through multiple modes rather than one. They relied on written materials and demonstration-based support, such as watching a nurse prepare and administer a medication, to anchor what they had been told verbally. In other words, the demand for staged, multimodal, and reinforced information appears to be a universal feature of learning to manage complex medication systems, not a special need of any particular group.
Where caregivers diverged was in how they engaged with and operationalised the information once they had it. Caregivers born overseas described difficulty processing complex verbal explanations delivered in a second language, and reported developing deliberate strategies to cope: asking staff to re-explain, arranging translation, and placing particular value on structured opportunities for multidisciplinary clarification and reassurance from the oncologists, nurses, and pharmacists involved in their child’s care. These families were not lacking motivation or attention; they were working against a system that assumed comprehension would follow a single spoken explanation. Their accounts suggest that what they needed most was not more information, but more structured opportunities to confirm that their understanding matched the intended one.
Caregivers born in Australia, by contrast, described a different failure mode. For them, the problem was less about processing language and more about inconsistency. They reported uncertainty arising when verbal instructions from one clinician conflicted with written materials, or when electronic information sources, such as patient portals or discharge summaries, did not align with what they had been told in person. This finding is technically important because it locates the vulnerability not in the caregiver’s literacy but in the coherence of the information system itself. When the same medication regimen is described differently across channels, even fluent, health-literate families are left to adjudicate the discrepancies on their own, often while managing a critically ill child.
That adjudication role emerged as one of the study’s most consequential themes. Across the sample, caregivers described functioning as key safety checkpoints within fragmented health systems. They cross-checked information between sources, caught discrepancies, and navigated inconsistencies in the absence of coordinated support. In safety-science terms, these parents were performing informal error detection and recovery work, absorbing the friction produced by discontinuities between hospital, community pharmacy, and home care. The study’s authors argue that this reality reframes the problem: medication information needs in paediatric oncology reflect the demands of managing complex medication systems rather than knowledge gaps alone. A family that asks the same question three times is not necessarily failing to learn; it may be performing quality control on a system that has given it reasons to doubt.
The practical implications follow directly from that reframing. If the bottleneck is system design rather than caregiver comprehension, then simply increasing the amount of information provided, more leaflets, longer counselling sessions, denser discharge packs, is unlikely to help and may worsen the overload caregivers described at treatment initiation. Instead, the researchers call for system-level approaches that improve the consistency, design, timing, reinforcement, and accessibility of medication information within routine care. Concretely, that points to aligning verbal, written, and electronic sources so they tell the same story; sequencing information so that the most critical instructions arrive when families can absorb them and the rest follows in stages; building in demonstration-based teaching alongside spoken and written formats; and creating structured, repeated opportunities for caregivers, particularly those navigating a second language, to seek clarification from the multidisciplinary team.
The study also carries a pointed message for health equity. In diverse populations, communication practices that assume shared language and understanding quietly redistribute risk onto the families least equipped to absorb it. The overseas-born caregivers in this study were actively compensating, through re-explanation and translation strategies, for a delivery model that was not designed with them in mind. Recognising staged, multimodal information delivery as a universal need, and structured clarification as an equity safeguard rather than an optional extra, would shift the burden of safety from the household back to the service. That shift is the study’s central argument, and it is one that health services designing paediatric oncology care, and indeed any complex home-based therapy, cannot afford to ignore.
The research, which forms part of the first author’s doctoral work at the University of Sydney and was supported by an Australian Government Research Training Program Stipend Scholarship and a Tour de Cure PhD Scholarship, was conducted with ethics approval from the Sydney Children’s Hospitals Network Human Research Ethics Committee. Its fifteen voices describe a common experience with uncommon clarity: parents of children with cancer are willing and able to be the last line of defence for medication safety, but a well-designed system should not need to rely on them to catch its own inconsistencies. The findings suggest that the next advance in paediatric medication safety will come not from telling families more, but from building information systems that are coherent enough that families can trust what they are told the first time.
Subject of Research: Medication information needs and use among caregivers of children with cancer in paediatric oncology
Article Title: Beyond knowledge gaps: service factors shaping caregiver use of medication information in paediatric oncology
Article References: Hansen, M. S., Castelino, R. L., Li, R., Govender, D., Bloomfield, J., Nagabushan, S., & Van, C. (2026). Beyond knowledge gaps: service factors shaping caregiver use of medication information in paediatric oncology. BMC Health Services Research. https://doi.org/10.1186/s12913-026-15258-8
Image Credits: AI Generated
DOI: 10.1186/s12913-026-15258-8
Keywords: paediatric oncology, medication safety, caregivers, health communication, health literacy, qualitative research, health services research, patient education, medication information, diverse populations, childhood cancer, Australia
News Source: Nathaniel Bowman. (October 12, 2026). When Information Overwhelms: How Service Design Shapes Medication Safety for Families Facing Childhood Cancer. Scienmag.
